The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.

Generation Investment Management has led the Swisscom-backed genomic testing platform developer's latest round, boosting its overall funding to $140m.

Autoimmune disease therapy spinout Cabaletta Bio's series B round brought its total to at least $88m allowed the university to pare back its shareholding.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

Medical device developer Ablative Solutions has closed the first tranche of its series D round having secured an undisclosed corporate backer.

The series A capital will support construction of a cellular production plant in China for the pharmaceutical services provider.

Martin Bauer's PRM Holdings unit has contributed to a round that will help Syqe expand use of its medical cannabis inhaler to other substances.

Qualcomm and existing backer Hyundai both invested in a $43.5m round for Immotor's EV battery rental spinoff that was led by US-China Green Fund.

LG, SBI, Hella and Hynix contributed to a second close of the road-mapping system developer's latest round, which already featured Intel Capital and Airbus Ventures.

Stanford-StartX Fund has returned to pump funding into electric skateboard manufacturer Boosted, helping to take the company’s total funding to $70m.